Community-Acquired Infections
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Community-Acquired Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.
    
			
			
				
				
					
						| Descriptor ID | D017714 | 
					
						| MeSH Number(s) | C01.539.234 | 
					
						| Concept/Terms | Community-Acquired InfectionsCommunity-Acquired InfectionsCommunity Acquired InfectionsInfections, Community-AcquiredCommunity-Acquired InfectionInfection, Community-AcquiredInfections, Community Acquired
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Community-Acquired Infections".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Community-Acquired Infections".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Community-Acquired Infections" by people in this website by year, and whether "Community-Acquired Infections" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2000 | 1 | 0 | 1 | 
| 2001 | 0 | 1 | 1 | 
| 2003 | 1 | 1 | 2 | 
| 2008 | 3 | 0 | 3 | 
| 2009 | 0 | 1 | 1 | 
| 2010 | 0 | 2 | 2 | 
| 2011 | 2 | 0 | 2 | 
| 2012 | 0 | 1 | 1 | 
| 2015 | 0 | 1 | 1 | 
| 2016 | 3 | 0 | 3 | 
| 2017 | 1 | 1 | 2 | 
| 2018 | 1 | 0 | 1 | 
| 2019 | 0 | 1 | 1 | 
| 2023 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Community-Acquired Infections" by people in Profiles.
						
					
								- 
								COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation. Crit Care. 2023 Jan 23; 27(1):34. 
- 
								Incidence of Clostridioides difficile infections among young and middle-aged adults: Veterans Health Administration. Infect Control Hosp Epidemiol. 2019 09; 40(9):997-1005. 
- 
								Testing for Coccidioidomycosis among Community-Acquired Pneumonia Patients, Southern California, USA1. Emerg Infect Dis. 2018 04; 24(4):779-781. 
- 
								Kawasaki Disease Substantially Impacts Health-Related Quality of Life. J Pediatr. 2018 02; 193:155-163.e5. 
- 
								Pediatric Readmissions After Hospitalizations for Lower Respiratory Infections. Pediatrics. 2017 Aug; 140(2). 
- 
								Predicting 2-Year Risk of Developing Pneumonia in Older Adults without Dementia. J Am Geriatr Soc. 2016 07; 64(7):1439-47. 
- 
								CURB-65 Performance Among Admitted and Discharged Emergency Department Patients With Community-acquired Pneumonia. Acad Emerg Med. 2016 Apr; 23(4):400-5. 
- 
								Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era. Pediatrics. 2016 Apr; 137(4). 
- 
								Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study. J Am Geriatr Soc. 2015 Mar; 63(3):476-85. 
- 
								Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med. 2013 Sep-Oct; 26(5):508-17.